Holen Sie sich die Stockscreener-App
74.03
2.82%
2.03
Vorhandelsmarkt:
74.02
-0.01
-0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$72.00
Offen:
$71.63
24-Stunden-Volumen:
13.56M
Relative Volume:
1.69
Marktkapitalisierung:
$93.98B
Einnahmen:
$393.94B
Nettoeinkommen (Verlust:
$428.00M
KGV:
193.49
EPS:
0.3826
Netto-Cashflow:
$6.29B
1W Leistung:
-9.15%
1M Leistung:
-7.01%
6M Leistung:
+24.13%
1J Leistung:
+29.13%
1-Tages-Spanne:
$71.42
$74.36
1-Wochen-Bereich:
$70.69
$84.00
52-Wochen-Spanne:
$53.36
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
74.03 | 91.40B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
294.02 | 256.08B | 447.57B | 12.81B | 16.08B | 13.19 |
|
ELV
Elevance Health Inc
|
341.85 | 71.77B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
272.38 | 72.15B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
194.01 | 25.01B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health Corporation $CVS Shares Sold by Bank of New York Mellon Corp - MarketBeat
CVS Health Corporation (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
CVS Pharmacy Review 2026: Why This Everyday Drugstore Is Quietly Becoming a Health Hub - AD HOC NEWS
CVS Antitrust Allegations Test Pharmacy Model And Long Term Turnaround - simplywall.st
CVS stock rebounds after Medicare Advantage rate shock; what investors watch next - TechStock²
CVS Health (CVS) Addresses Fertility Coverage for LGBTQ+ Nationw - GuruFocus
CVS Health Corp. (CVS) technical analysisCVS Health (NYSE:CVS) - Benzinga
CVS stock rebounds after Medicare Advantage rate scare; what investors watch next - TechStock²
UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs - Benzinga
CVS Health (CVS) Receives Maintained 'Buy' Rating with Adjusted Price Target | CVS Stock News - GuruFocus
CVS Health (NYSE:CVS) Price Target Cut to $90.00 by Analysts at Argus - MarketBeat
The CVS Turnaround: A 2026 Deep-Dive into the Future of Integrated Healthcare - FinancialContent
What’s Behind The Crash In CVS Stock? - Trefis
UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates - AOL.com
CVS Stock (-14%): Medicare Rate Shock Sparks Institutional Distribution - Trefis
'Big Short' Is Long On Molina Healthcare Stock—Was He Big Wrong? - Benzinga
UnitedHealth, CVS, Other Insurer Stocks Slide on Medicare Proposal - The Wall Street Journal
Healthcare: Managed Care Stocks Plunge Following Almost-Flat Medicare Rate Proposal - Morningstar
CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next - TechStock²
Health Care Slides After Medicare Rates Proposal -- Health Care Roundup - marketscreener.com
Humana, UnitedHealth, CVS Stocks Tumble After Trump Medicare Rates Surprise - Barron's
Why CVS Health (CVS) Shares Are Plunging Today - Finviz
Expert Outlook: CVS Health Through The Eyes Of 17 Analysts - Benzinga
S&P 500 Hits New Records, GM Stock Jumps 8% On Earnings: What's Moving Markets Tuesday? - Benzinga
Insurers Fall as Era of Government-Backed Growth Grinds to Halt - Bloomberg.com
UnitedHealth leads $80 billion insurer rout on bleak Medicare Advantage proposal - Reuters
CVS Health (NYSE:CVS) Shares Gap Down After Analyst Downgrade - MarketBeat
CVS Receives Lowered Price Target From B of A Securities, Mainta - GuruFocus
Bank of America Lowers CVS Health (NYSE:CVS) Price Target to $95.00 - MarketBeat
US proposes slight rise in 2027 Medicare insurer payments, shares fall - Reuters
CVS Health at the Crossroads: Navigating the Medicare Advantage Rate Shock and the Joyner Era - FinancialContent
CVS Stock Outperforms Market: Strong Buy Consensus & 2025 Outlook | 2026 AnalysisNews and Statistics - IndexBox
Humana, Alignment Healthcare, Nucor And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Is It Time To Reassess CVS Health (CVS) After Its 55% One Year Share Price Rise - simplywall.st
Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling - Benzinga
CVS Health stock price target lowered to $95 by BofA on CMS rate proposal - Investing.com
Are Wall Street Analysts Predicting CVS Health Stock Will Climb or Sink? - Barchart.com
UnitedHealth, Humana, CVS shares get crushed as Trump administration proposes lower-than-expected Medicare insurer rates - MSN
After-hours movers: Humana, UnitedHealth, CVS Health, Sanmina and more - Investing.com
CVS Health, UnitedHealth Group stocks tumble on lower Medicare rate proposal - Investing.com
Hiding from Shareholders: CVS Health - The National Center
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation - Healthcare Dive
University of Maryland, CVS Health partner to boost pharmacy workforce - Drug Store News
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Parthenon LLC Sells 13,389 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Lbp Am Sa - MarketBeat
Ultimate CVS Stock & Bitcoin USD Investment Guide - Vocal
CVS Health Corporation $CVS Shares Purchased by Callahan Advisors LLC - MarketBeat
The Zacks Analyst Blog Microsoft, Anheuser-Busch CVS, and Stran & Co - Zacks Investment Research
Woonsocket-based CVS battles Congress, FTC and courts while positioning itself as healthcare reform partner - The Business Journals
Mitsubishi UFJ Trust & Banking Corp Purchases 33,736 Shares of CVS Health Corporation $CVS - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.86%
6.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):